|
Market Cap (1-Jul) $176,237,888 (1,192nd) |
Close (28-Sep) $0.205 |
Volume (28-Sep) 0 |
Shortsold (21-Sep) 297,501 (0.03%) (573rd) |
|
52w High $0.000 |
52w Low $0.000 |
P/E - |
EPS -0.009 |
RAP released this announcement to the ASX on 12 March 2021, 17:06. The announcement is not marked as price sensitive, and is 16 page(s) in length and 412.59kb in size.
You can view all announcements from RAP and see how they appear on a price chart on the announcements page.
At the date of this announcement, RAP was 0.180% short sold according to ASIC data. It was ranked the 385th most shorted stock on the ASX. It remains ranked 573rd as of the latest reported data (21 September 2022).
| Other Recent Announcements from RAP | |
|---|---|
| Removal from Official List | 27 September 2022, 11:58 |
| Scheme of Arrangement has been Implemented | 26 September 2022, 16:28 |
| Ceasing to be a substantial holder | 20 September 2022, 8:09 |
| Section 708A Notice and Appendix 2A | 12 March 2021, 17:06 |
| S&P DJI Announces March 2021 Quarterly Rebalance | 12 March 2021, 17:02 |
| ResApp grants SDK licence to AstraZeneca for asthma program | 12 March 2021, 9:01 |
| Clinical study to develop COVID-19 screening test | 11 March 2021, 10:07 |
You must be logged in to post a reply.
ResApp Health 